Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?
Novavax vaccine shows “markedly stronger” responses in early human trials
Related Articles
Breathing polluted air increases risk of osteoporosis, growing evidence shows
Pollutants can interfere with bone growth in numerous ways, studies suggest
A photoluminescent hydrogen-bonded biomass aerogel for sustainable radiative cooling
Passive radiant cooling is a potentially sustainable thermal management strategy amid escalating global climate change. However, petrochemical-derived cooling materials often face efficiency challenges owing to…
Einstein’s Oxford years
Long overlooked by biographers, the physicist’s time at the renowned British university—and his reasons for leaving—are worth revisiting
The anatomy of brainwashing
Glymphatic-lymphatic brain cleansing may reveal new therapeutic strategies
Cellular senescence in normal physiology
Long associated with aging, senescent cells can promote health and have physiological roles
From homeless to Ph.D.: How I found my way into research
“For much of my scientific training I feared I was behind my peers,” this grad student writes
Science’s 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention
A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who…
The emerging era of cell engineering: Harnessing the modularity of cells to program complex biological function
A new era of biological engineering is emerging in which living cells are used as building blocks to address therapeutic challenges. These efforts are distinct…
Whole-body magnetic resonance imaging at 0.05 Tesla
Despite a half-century of advancements, global magnetic resonance imaging (MRI) accessibility remains limited and uneven, hindering its full potential in health care. Initially, MRI development…